TTR‐CMP has a better prognosis than AL‐CMP.5 In some cases, the delay in obtaining a bone marrow biopsy for diagnosis invariably results in therapeutic delay that may prove fatal in AL‐CMP; thus, a noninvasive measurement to assist clinicians in selecting a bone marrow biopsy sooner may be useful. The gene discussed is TTR; the disease is axial length measurement.